OLD National Bancorp IN raised its holdings in Danaher Co. (NYSE:DHR) by 0.1% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 119,242 shares of the conglomerate’s stock after acquiring an additional 158 shares during the quarter. Danaher makes up about 0.9% of OLD National Bancorp IN’s portfolio, making the stock its 29th largest holding. OLD National Bancorp IN’s holdings in Danaher were worth $17,222,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. MBM Wealth Consultants LLC boosted its stake in shares of Danaher by 2.0% in the 2nd quarter. MBM Wealth Consultants LLC now owns 3,701 shares of the conglomerate’s stock valued at $529,000 after purchasing an additional 74 shares during the last quarter. Mechanics Bank Trust Department boosted its stake in Danaher by 1.7% during the second quarter. Mechanics Bank Trust Department now owns 4,384 shares of the conglomerate’s stock worth $627,000 after acquiring an additional 75 shares in the last quarter. Copperwynd Financial LLC boosted its stake in Danaher by 1.9% during the second quarter. Copperwynd Financial LLC now owns 4,144 shares of the conglomerate’s stock worth $592,000 after acquiring an additional 79 shares in the last quarter. Lincoln National Corp boosted its stake in Danaher by 3.1% during the second quarter. Lincoln National Corp now owns 2,666 shares of the conglomerate’s stock worth $381,000 after acquiring an additional 81 shares in the last quarter. Finally, Meridian Financial Partners LLC boosted its stake in Danaher by 3.0% during the second quarter. Meridian Financial Partners LLC now owns 2,847 shares of the conglomerate’s stock worth $411,000 after acquiring an additional 83 shares in the last quarter. Hedge funds and other institutional investors own 78.44% of the company’s stock.
In other Danaher news, CAO Robert S. Lutz sold 14,668 shares of the firm’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $143.28, for a total value of $2,101,631.04. Following the transaction, the chief accounting officer now directly owns 21,054 shares of the company’s stock, valued at $3,016,617.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Brian W. Ellis sold 1,010 shares of the firm’s stock in a transaction on Friday, July 26th. The shares were sold at an average price of $144.04, for a total transaction of $145,480.40. Following the completion of the transaction, the insider now directly owns 20,889 shares in the company, valued at $3,008,851.56. The disclosure for this sale can be found here. 11.40% of the stock is currently owned by company insiders.
Shares of Danaher stock traded down $0.15 during trading hours on Tuesday, reaching $138.08. The company’s stock had a trading volume of 80,950 shares, compared to its average volume of 1,950,729. Danaher Co. has a one year low of $94.59 and a one year high of $147.33. The company has a market capitalization of $99.00 billion, a P/E ratio of 30.58, a P/E/G ratio of 2.31 and a beta of 0.94. The stock’s fifty day simple moving average is $141.03 and its two-hundred day simple moving average is $137.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.91 and a current ratio of 2.32.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, September 27th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.49%. The ex-dividend date of this dividend is Thursday, September 26th. Danaher’s dividend payout ratio (DPR) is 15.04%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Story: The components of the Stochastic Momentum Index
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.